Iris Unito Prodmetadata only
Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC)
effectivene, real word evidence, safety, tofacitinib, ulcerative coliti, vedolizumab
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 418066
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.